Free Guide: FDA vs. EMA Drug Approval Pathways
A practical, 65-page strategic guide for sponsors planning clinical trials and drug approval submissions across the US and EU.
What’s inside
- Legal foundations and regulatory architecture of FDA and EMA
- NDA, BLA, and MAA submission requirements compared side by side
- Pre-submission interactions, user fees, and review clocks
- FDA expedited programs: Fast Track, Breakthrough Therapy, Accelerated Approval, Priority Review
- EU expedited pathways: PRIME, Accelerated Assessment, Conditional Marketing Authorisation
- Orphan drug designations, post-approval changes, and pharmacovigilance
- Practical guidance for designing a global regulatory strategy
Written by Juan Manuel Fernández, ECT Pharma Consulting.
Get your free copy
Enter your name and email — we’ll send you the download link instantly.